Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.6312
-0.0738 (-10.47%)
At close: May 12, 2025, 4:00 PM
0.6312
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT
MTNB Market Cap
MTNB has a market cap or net worth of $3.21 million as of May 12, 2025. Its market cap has decreased by -91.87% in one year.
Market Cap
3.21M
Enterprise Value
-1.18M
1-Year Change
-91.87%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $3.21M, a decrease of -98.56%. That is a compound annual growth rate of -40.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 3.20M | 23.08% |
| Dec 31, 2024 | 2.60M | -94.47% |
| Dec 29, 2023 | 47.00M | -56.64% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |